Reuters (February 15)
“Japan’s journey back to normality has just taken an unwelcome turn. The world’s third-largest economy in U.S. dollar terms ceded the title to Germany on Thursday” as Japan simultaneously slipped into a recession. “More unnerving is a slew of weak data making it harder for the Bank of Japan to justify hiking rates and officially ending its era of ultra-easy monetary policy.”
Tags: BOJ, Economy, Germany, Japan, Monetary policy, Normality, Rates, Recession, Third-largest, U.S., Unnerving, Uultra-easy, Weak data
Financial Times (November 10)
“After the long night of Covid-19, a faint glow is visible on the horizon.” Pfizer’s 90% efficacy is more than we could dream for in a vacine, but the “euphoria should be tempered; any return to normality will take time…. Science has made a breakthrough. But don’t throw away your face covering just yet.”
Tags: 90%, Breakthrough, COVID-19, Efficacy, Euphoria, Normality, Pfizer, Science, Tempered, Time, Vaccine
Investment Week (March 30)
“The past two weeks have seen a major transition in central bank philosophy, and possibly a renewed sense of coordination.” Central bankers seem to be signaling that they will not push further with negative rates and will instead embrace other methods, some non-conventional. “So far, markets have been euphoric at this turn away from the abyss and back towards some kind of ‘normality.’”
Tags: Central bank, Coordination, Markets, Methods, Negative rates, Non-conventional, Normality, Philosophy, Signaling, Transition
